{"address1": "Darwinweg 24", "city": "Leiden", "zip": "2333 CR", "country": "Netherlands", "phone": "31 71 524 7400", "fax": "31 71 524 7445", "website": "https://www.pharming.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Sijmen  de Vries M.B.A., M.D.", "age": 65, "title": "Advisor", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 1438000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Fabrice  Chouraqui Ph.D.", "title": "CEO & Executive Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeroen  Wakkerman", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mireille  Sanders M.Sc.", "age": 56, "title": "Chief Operations Officer", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susanne  Embleton", "title": "Investor Relations Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ruud  Van Outersterp", "age": 60, "title": "Chief Ethics & Compliance Officer", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Ines  Bernal", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anurag  Relan M.D., MPH", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen  Toor", "age": 53, "title": "Chief Commercial Officer & GM Americas", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alexander  Breidenbach M.B.A.", "age": 61, "title": "Chief Business Officer", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.79, "open": 8.31, "dayLow": 8.1, "dayHigh": 8.6998, "regularMarketPreviousClose": 8.79, "regularMarketOpen": 8.31, "regularMarketDayLow": 8.1, "regularMarketDayHigh": 8.6998, "payoutRatio": 0.0, "beta": 0.639, "volume": 4400, "regularMarketVolume": 4400, "averageVolume": 6325, "averageVolume10days": 2810, "averageDailyVolume10Day": 2810, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 584964992, "fiftyTwoWeekLow": 6.65, "fiftyTwoWeekHigh": 11.3, "priceToSalesTrailing12Months": 1.9682537, "fiftyDayAverage": 8.76936, "twoHundredDayAverage": 8.442875, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6325663232, "forwardPE": 2463.7998, "profitMargins": -0.037100002, "floatShares": 711258400, "sharesOutstanding": 67835400, "sharesShort": 5764, "sharesShortPriorMonth": 5259, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0001, "heldPercentInsiders": 0.0, "heldPercentInstitutions": 0.00078, "shortRatio": 0.75, "shortPercentOfFloat": 0.0001, "impliedSharesOutstanding": 70575296, "bookValue": 0.3, "priceToBook": 28.744331, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -11027000, "trailingEps": -0.16, "enterpriseToRevenue": 21.284, "enterpriseToEbitda": 849.196, "52WeekChange": -0.21322995, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 8.6233, "targetHighPrice": 39.0, "targetLowPrice": 14.0, "targetMeanPrice": 30.0, "targetMedianPrice": 37.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 167892992, "totalCashPerShare": 0.227, "ebitda": 7449000, "totalDebt": 112314000, "quickRatio": 3.021, "currentRatio": 3.776, "totalRevenue": 297200000, "debtToEquity": 50.623, "revenuePerShare": 4.31, "returnOnAssets": -0.01248, "returnOnEquity": -0.05005, "grossProfits": 261800992, "freeCashflow": 1116875, "operatingCashflow": -1793000, "revenueGrowth": 0.141, "grossMargins": 0.88088995, "ebitdaMargins": 0.02506, "operatingMargins": 0.084139995, "financialCurrency": "USD", "symbol": "PHAR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1608733800000, "marketState": "PRE", "regularMarketChangePercent": -1.8964775, "regularMarketPrice": 8.6233, "shortName": "Pharming Group N.V.", "longName": "Pharming Group N.V.", "regularMarketChange": -0.16670036, "regularMarketDayRange": "8.1 - 8.6998", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 6325, "fiftyTwoWeekLowChange": 1.9732995, "fiftyTwoWeekLowChangePercent": 0.29673678, "fiftyTwoWeekRange": "6.65 - 11.3", "fiftyTwoWeekHighChange": -2.6767006, "fiftyTwoWeekHighChangePercent": -0.23687616, "fiftyTwoWeekChangePercent": -21.322996, "earningsTimestamp": 1746685800, "earningsTimestampStart": 1746685800, "earningsTimestampEnd": 1746685800, "earningsCallTimestampStart": 1741869000, "earningsCallTimestampEnd": 1741869000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.16, "epsCurrentYear": -0.032, "priceEpsCurrentYear": -269.4781, "fiftyDayAverageChange": -0.14605999, "fiftyDayAverageChangePercent": -0.016655719, "twoHundredDayAverageChange": 0.18042469, "twoHundredDayAverageChangePercent": 0.021370053, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-12-22", "averageAnalystRating": "1.3 - Strong Buy", "corporateActions": [], "regularMarketTime": 1743537600, "exchange": "NGM", "messageBoardId": "finmb_32943", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Pharming", "trailingPegRatio": null}